Petr Kocis, Ph.D.

Fmr. Global Head Exploratory Chemistry, Global Enabling Sciences & Technologies, AstraZeneca
During the last two decades Dr. Kocis has been actively involved in drug discovery research in cancer, immunodeficiencies, asthma and provided drug lead discovery leadership at Hoechst-Marion-Roussell, Zeneca Pharmaceuticals and AstraZeneca, lately as Global Head of Exploratory Chemistry, Discovery Capabilities & Sciences, AstraZeneca and as Associate Director of Global Enabling Science & Technologies. Dr. Kocis is one of the pioneers of combinatorial chemistry field and chemical libraries. At Zeneca Pharmaceuticals he co-build the US Chemical Technologies group as a multidisciplinary department of Global Enabling Science & Technology with novel EST technology that was industrialized within the Zeneca (US-UK axis) across a number of therapeutic domains including cancer, infection, cardiovascular /kinases, phosphatases, GPCRs. Dr. Kocis also contributed to the formulation of medicinally relevant space for AstraZeneca Compound Collection. He is a recipient of R&D Director’s Award for Creativity and Innovation, Zeneca Pharmaceuticals, a recipient of Henry Christian Award for Excellence in Research by Merck. Dr. Kocis serves as the founding Editor-in-Chief of the Current Drug Discovery Technologies. He is on the editorial board of several journals including Drugs of the Future and serves on the Scientific Advisory Board of several companies including EATRIS. Dr. Kocis is the author or coauthor of numerous scientific papers, book chapters and patents. His research interest is the multidimensional challenges of drug discovery, novel technologies, modern medicinal chemistry, chemical and biology space mapping, and data visualization.